MoCRA Compliance Checklist for US Brands Manufacturing in Korea

You’ve done the hard part. You found a Korean manufacturer, you have your formulas, and you’re ready to build the K-beauty brand you’ve been planning for months.

Then someone mentions MoCRA compliance — and suddenly you’re looking at a wall of FDA regulatory language trying to figure out what any of it actually means for you, as a US brand owner sourcing from Korea.

Here’s the uncomfortable truth that nobody in the sourcing space is talking about: Amazon removed thousands of cosmetic listings in 2024 for MoCRA non-compliance, and US Customs and Border Protection is actively detaining Korean cosmetic shipments at the border. This isn’t a future problem. It’s a right-now problem.

But it’s also a manageable one — if you know what to check before your products leave Korea. This is that checklist.

What MoCRA Actually Requires (The Quick Version)

Before MoCRA, the US cosmetics industry was operating under regulations from 1938. No, really — 1938. Brands could sell cosmetics with almost zero required interaction with the FDA. That era is over. MoCRA — the Modernization of Cosmetics Regulation Act of 2022 — established five core requirements that now apply to anyone selling cosmetics in the US market. As a US brand owner sourcing from Korea, every single one of these touches you directly. Some of them touch your Korean manufacturer too. That’s why the compliance process needs to start before production — not after your shipment clears customs.

Your Korean Manufacturer Must Be FDA-Registered

Under MoCRA, any facility that manufactures or processes cosmetic products distributed in the US must be registered with the FDA. This applies to your Korean ODM or OEM. Registration is free through a system called Cosmetics Direct and needs to be renewed every two years. Most established Korean manufacturers are already registered — but not all. Ask yours directly: “Do you have an active FDA facility registration under MoCRA? Can you share your FEI number?” If they hesitate, that’s your answer. An unregistered facility is exactly what gets a shipment detained at the border.

You Are the “Responsible Person” — And That Means Something

Under MoCRA, the “responsible person” is the manufacturer, packer, or distributor whose name appears on the product label. For most indie K-beauty brands, that’s you. This means you bear the compliance obligations for product listing, adverse event reporting, and safety substantiation. Your Korean manufacturer handles their side (facility registration). You handle yours. Just because your factory manages production doesn’t mean they manage your FDA compliance.

Every Product You Sell Needs to Be Listed with the FDA

Product listing is separate from facility registration, and it’s your responsibility. List every cosmetic product you sell in the US with the FDA through Cosmetics Direct, including the full ingredient list. Update your listings annually. The small business exemption exists if your average US cosmetic sales are under $1 million over three years, but it has carve-outs for eye products, injectables, and products that alter appearance for more than 24 hours. When in doubt, list anyway. It’s free and protects you as your brand grows.

Labeling: Where Most Import Problems Actually Start

Korean labeling regulations are different from US FDA requirements. A label that’s perfectly compliant in Korea can get your shipment detained at a US port. Your Korean manufacturer is not responsible for making sure your label meets US requirements. That’s on you. Your US label needs: a product identity statement, net quantity on the front panel, your name and US address as the distributor, a full ingredient list in descending order using INCI names, and any required warnings. All in English. If you keep Korean text, all required information must also appear in English. Get your final label artwork reviewed before you go to print. A label review costs a fraction of what it costs to reprint packaging or have a shipment refused at the border.

Watch Your Claims — This Is What Killed Thousands of Amazon Listings

Cosmetic claims describe appearance: “visibly reduces the look of fine lines,” “leaves skin looking more radiant.” These are fine. Drug claims describe structure or function: “reduces wrinkles,” “stimulates collagen production,” “treats acne.” The FDA considers these drug claims — meaning your product needs FDA approval before it can be sold. Amazon’s compliance systems scan listings for drug claim language. If your title says “anti-aging treatment” or your bullets say “repairs skin barrier,” your listing gets deactivated. This happened en masse in 2024 and caught plenty of legitimate brands. K-beauty marketing tends to be more efficacy-forward than what US regulations allow. Review every piece of copy: your label, your Amazon listing, your website, your social media.

Adverse Event Reporting and Safety Substantiation

If a customer has a serious adverse reaction — hospitalization, significant disfigurement, serious infection, or anything requiring medical intervention — you must report it to the FDA within 15 business days. You need to retain records for at least six years. Set up this process before your first sale: a designated contact email for complaints, a log to document reports, and clarity on what “serious” means under MoCRA. On safety substantiation: you need to maintain records supporting the adequate safety of your products. The FDA won’t test your product before you sell it, but they can ask for your records. Request all safety documentation from your Korean manufacturer before finalizing production — stability testing, microbial testing, challenge testing. Reputable Korean ODMs have this data. Make sure you get it and keep it organized.

What CBP Actually Looks at When Your Shipment Arrives

When your Korean skincare shipment arrives at a US port, CBP files entry documentation that triggers FDA review through a system called PREDICT. Things that reliably get shipments detained: unregistered manufacturing facilities, labeling with drug claims, unapproved color additives, products from manufacturers on FDA import alerts, and documentation mismatches. Work with a customs broker experienced in cosmetics imports. They know which documentation to prepare, which Affirmation of Compliance codes to include, and how to respond if your shipment gets flagged. A detained shipment costs far more than broker fees.

Your Pre-Launch MoCRA Checklist

Before production: Confirm your Korean manufacturer has an active FDA facility registration and get their FEI number. Request full INCI ingredient lists and all safety/testing documentation for each product.

During packaging design: Review every label element against FDA requirements. Audit all marketing copy for drug claims. Have your final artwork reviewed before print.

Before shipping: List all products with the FDA through Cosmetics Direct (free). Set up your adverse event reporting process. Confirm your customs broker has all import documentation ready.

Ready to create your own K-beauty line? Get a free manufacturing quote from ALTA MEET.

Get Your Free Quote